nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—osteoarthritis—Prednisone—Crohn's disease	0.377	1	CpDpCtD
Etodolac—PTGS2—Crohn's disease	0.123	0.529	CbGaD
Etodolac—ALB—Crohn's disease	0.11	0.471	CbGaD
Etodolac—PTGS2—Balsalazide—Crohn's disease	0.0722	0.229	CbGbCtD
Etodolac—PTGS1—Balsalazide—Crohn's disease	0.061	0.193	CbGbCtD
Etodolac—PTGS2—Mesalazine—Crohn's disease	0.0577	0.183	CbGbCtD
Etodolac—PTGS1—Mesalazine—Crohn's disease	0.0487	0.155	CbGbCtD
Etodolac—PTGS2—Sulfasalazine—Crohn's disease	0.0322	0.102	CbGbCtD
Etodolac—PTGS1—Sulfasalazine—Crohn's disease	0.0272	0.0864	CbGbCtD
Etodolac—ALB—Prednisone—Crohn's disease	0.0163	0.0516	CbGbCtD
Etodolac—Ulcer—Mercaptopurine—Crohn's disease	0.000744	0.0126	CcSEcCtD
Etodolac—Hepatic necrosis—Mesalazine—Crohn's disease	0.000657	0.0111	CcSEcCtD
Etodolac—Mouth ulceration—Mercaptopurine—Crohn's disease	0.000636	0.0107	CcSEcCtD
Etodolac—Sepsis—Mercaptopurine—Crohn's disease	0.000611	0.0103	CcSEcCtD
Etodolac—Nephritis interstitial—Mesalazine—Crohn's disease	0.000566	0.00956	CcSEcCtD
Etodolac—Burning sensation—Mesalazine—Crohn's disease	0.00055	0.00929	CcSEcCtD
Etodolac—Meningitis—Prednisone—Crohn's disease	0.000521	0.00881	CcSEcCtD
Etodolac—Tubulointerstitial nephritis—Mesalazine—Crohn's disease	0.000499	0.00843	CcSEcCtD
Etodolac—Rash pustular—Mesalazine—Crohn's disease	0.000479	0.00809	CcSEcCtD
Etodolac—Jaundice cholestatic—Azathioprine—Crohn's disease	0.000477	0.00806	CcSEcCtD
Etodolac—UGT1A10—digestive system—Crohn's disease	0.000456	0.174	CbGeAlD
Etodolac—Jaundice cholestatic—Mesalazine—Crohn's disease	0.000435	0.00734	CcSEcCtD
Etodolac—Proteinuria—Mesalazine—Crohn's disease	0.000435	0.00734	CcSEcCtD
Etodolac—Pancreatitis—Mercaptopurine—Crohn's disease	0.000433	0.00731	CcSEcCtD
Etodolac—Vasculitis—Azathioprine—Crohn's disease	0.00043	0.00726	CcSEcCtD
Etodolac—Protein urine present—Mesalazine—Crohn's disease	0.000429	0.00724	CcSEcCtD
Etodolac—Rectal haemorrhage—Mesalazine—Crohn's disease	0.000423	0.00714	CcSEcCtD
Etodolac—Pancytopenia—Mercaptopurine—Crohn's disease	0.000419	0.00708	CcSEcCtD
Etodolac—Hepatic enzyme increased—Mesalazine—Crohn's disease	0.000404	0.00682	CcSEcCtD
Etodolac—Colitis—Azathioprine—Crohn's disease	0.000403	0.0068	CcSEcCtD
Etodolac—Aplastic anaemia—Azathioprine—Crohn's disease	0.000394	0.00665	CcSEcCtD
Etodolac—Stomatitis—Mercaptopurine—Crohn's disease	0.000384	0.00648	CcSEcCtD
Etodolac—Eructation—Mesalazine—Crohn's disease	0.000375	0.00634	CcSEcCtD
Etodolac—Melaena—Mesalazine—Crohn's disease	0.000373	0.0063	CcSEcCtD
Etodolac—Cystitis noninfective—Mesalazine—Crohn's disease	0.000373	0.0063	CcSEcCtD
Etodolac—Cystitis—Mesalazine—Crohn's disease	0.000369	0.00623	CcSEcCtD
Etodolac—Colitis—Mesalazine—Crohn's disease	0.000367	0.0062	CcSEcCtD
Etodolac—Skin exfoliation—Mesalazine—Crohn's disease	0.000365	0.00616	CcSEcCtD
Etodolac—Blood urea increased—Mesalazine—Crohn's disease	0.000361	0.00609	CcSEcCtD
Etodolac—Aplastic anaemia—Mesalazine—Crohn's disease	0.000359	0.00606	CcSEcCtD
Etodolac—Coma—Mesalazine—Crohn's disease	0.000349	0.0059	CcSEcCtD
Etodolac—Mouth ulceration—Mesalazine—Crohn's disease	0.000345	0.00583	CcSEcCtD
Etodolac—Ecchymosis—Mesalazine—Crohn's disease	0.000345	0.00583	CcSEcCtD
Etodolac—Bladder pain—Mesalazine—Crohn's disease	0.000345	0.00583	CcSEcCtD
Etodolac—Hepatic failure—Azathioprine—Crohn's disease	0.000339	0.00572	CcSEcCtD
Etodolac—Lymphadenopathy—Mesalazine—Crohn's disease	0.000325	0.00549	CcSEcCtD
Etodolac—UGT1A3—digestive system—Crohn's disease	0.000321	0.122	CbGeAlD
Etodolac—Photosensitivity—Mesalazine—Crohn's disease	0.000316	0.00533	CcSEcCtD
Etodolac—Alopecia—Mercaptopurine—Crohn's disease	0.000312	0.00528	CcSEcCtD
Etodolac—Deafness—Mesalazine—Crohn's disease	0.00031	0.00524	CcSEcCtD
Etodolac—Hepatic failure—Mesalazine—Crohn's disease	0.000308	0.00521	CcSEcCtD
Etodolac—Peptic ulcer—Prednisone—Crohn's disease	0.000302	0.00511	CcSEcCtD
Etodolac—Renal impairment—Mesalazine—Crohn's disease	0.000291	0.00492	CcSEcCtD
Etodolac—Thirst—Mesalazine—Crohn's disease	0.000291	0.00492	CcSEcCtD
Etodolac—Dermatitis bullous—Mesalazine—Crohn's disease	0.00029	0.0049	CcSEcCtD
Etodolac—Anaemia—Mercaptopurine—Crohn's disease	0.000284	0.0048	CcSEcCtD
Etodolac—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.000277	0.00468	CcSEcCtD
Etodolac—Leukopenia—Mercaptopurine—Crohn's disease	0.000275	0.00465	CcSEcCtD
Etodolac—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.000274	0.00463	CcSEcCtD
Etodolac—ALB—gall bladder—Crohn's disease	0.000268	0.102	CbGeAlD
Etodolac—Arthralgia—Mercaptopurine—Crohn's disease	0.000262	0.00442	CcSEcCtD
Etodolac—Pancreatitis—Azathioprine—Crohn's disease	0.000258	0.00436	CcSEcCtD
Etodolac—Abdominal pain upper—Mesalazine—Crohn's disease	0.000253	0.00428	CcSEcCtD
Etodolac—Abdominal discomfort—Azathioprine—Crohn's disease	0.000252	0.00426	CcSEcCtD
Etodolac—Oedema—Mercaptopurine—Crohn's disease	0.000251	0.00424	CcSEcCtD
Etodolac—Pancytopenia—Azathioprine—Crohn's disease	0.00025	0.00422	CcSEcCtD
Etodolac—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000246	0.00415	CcSEcCtD
Etodolac—Gastritis—Mesalazine—Crohn's disease	0.000245	0.00415	CcSEcCtD
Etodolac—Abdominal distension—Mesalazine—Crohn's disease	0.000241	0.00408	CcSEcCtD
Etodolac—Asthma—Mesalazine—Crohn's disease	0.00024	0.00405	CcSEcCtD
Etodolac—Anorexia—Mercaptopurine—Crohn's disease	0.000239	0.00404	CcSEcCtD
Etodolac—Eosinophilia—Mesalazine—Crohn's disease	0.000237	0.00401	CcSEcCtD
Etodolac—Pneumonia—Azathioprine—Crohn's disease	0.000236	0.00399	CcSEcCtD
Etodolac—Bronchospasm—Mesalazine—Crohn's disease	0.000236	0.00398	CcSEcCtD
Etodolac—Pancreatitis—Mesalazine—Crohn's disease	0.000235	0.00397	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000233	0.00393	CcSEcCtD
Etodolac—Bronchitis—Mesalazine—Crohn's disease	0.00023	0.00389	CcSEcCtD
Etodolac—Abdominal discomfort—Mesalazine—Crohn's disease	0.00023	0.00388	CcSEcCtD
Etodolac—UGT1A9—digestive system—Crohn's disease	0.000229	0.0872	CbGeAlD
Etodolac—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000229	0.00386	CcSEcCtD
Etodolac—Pancytopenia—Mesalazine—Crohn's disease	0.000228	0.00384	CcSEcCtD
Etodolac—Dysuria—Mesalazine—Crohn's disease	0.000224	0.00379	CcSEcCtD
Etodolac—Neutropenia—Mesalazine—Crohn's disease	0.000224	0.00379	CcSEcCtD
Etodolac—Pollakiuria—Mesalazine—Crohn's disease	0.000221	0.00374	CcSEcCtD
Etodolac—Agranulocytosis—Azathioprine—Crohn's disease	0.000219	0.0037	CcSEcCtD
Etodolac—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000219	0.0037	CcSEcCtD
Etodolac—Decreased appetite—Mercaptopurine—Crohn's disease	0.000218	0.00369	CcSEcCtD
Etodolac—Pneumonia—Mesalazine—Crohn's disease	0.000215	0.00363	CcSEcCtD
Etodolac—Ulcer—Prednisone—Crohn's disease	0.000214	0.00361	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000212	0.00358	CcSEcCtD
Etodolac—Haemoglobin—Azathioprine—Crohn's disease	0.000212	0.00358	CcSEcCtD
Etodolac—Haemorrhage—Azathioprine—Crohn's disease	0.000211	0.00356	CcSEcCtD
Etodolac—Renal failure—Mesalazine—Crohn's disease	0.00021	0.00355	CcSEcCtD
Etodolac—Stomatitis—Mesalazine—Crohn's disease	0.000208	0.00352	CcSEcCtD
Etodolac—Jaundice—Mesalazine—Crohn's disease	0.000208	0.00352	CcSEcCtD
Etodolac—Conjunctivitis—Mesalazine—Crohn's disease	0.000208	0.00351	CcSEcCtD
Etodolac—Vasculitis—Prednisone—Crohn's disease	0.000207	0.0035	CcSEcCtD
Etodolac—Sweating—Mesalazine—Crohn's disease	0.000205	0.00346	CcSEcCtD
Etodolac—Haematuria—Mesalazine—Crohn's disease	0.000204	0.00344	CcSEcCtD
Etodolac—Sinusitis—Mesalazine—Crohn's disease	0.0002	0.00339	CcSEcCtD
Etodolac—Agranulocytosis—Mesalazine—Crohn's disease	0.000199	0.00337	CcSEcCtD
Etodolac—Erythema multiforme—Azathioprine—Crohn's disease	0.000199	0.00336	CcSEcCtD
Etodolac—Body temperature increased—Mercaptopurine—Crohn's disease	0.000198	0.00335	CcSEcCtD
Etodolac—Skin exfoliation—Prednisone—Crohn's disease	0.000193	0.00326	CcSEcCtD
Etodolac—Haemoglobin—Mesalazine—Crohn's disease	0.000193	0.00326	CcSEcCtD
Etodolac—Rhinitis—Mesalazine—Crohn's disease	0.000192	0.00325	CcSEcCtD
Etodolac—Haemorrhage—Mesalazine—Crohn's disease	0.000192	0.00324	CcSEcCtD
Etodolac—Hepatitis—Mesalazine—Crohn's disease	0.000192	0.00324	CcSEcCtD
Etodolac—Pharyngitis—Mesalazine—Crohn's disease	0.00019	0.00322	CcSEcCtD
Etodolac—Chills—Azathioprine—Crohn's disease	0.000189	0.00319	CcSEcCtD
Etodolac—Arrhythmia—Azathioprine—Crohn's disease	0.000188	0.00318	CcSEcCtD
Etodolac—Alopecia—Azathioprine—Crohn's disease	0.000186	0.00314	CcSEcCtD
Etodolac—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000185	0.00313	CcSEcCtD
Etodolac—Oesophagitis—Prednisone—Crohn's disease	0.000185	0.00312	CcSEcCtD
Etodolac—UGT2B7—digestive system—Crohn's disease	0.000185	0.0703	CbGeAlD
Etodolac—Ecchymosis—Prednisone—Crohn's disease	0.000183	0.00309	CcSEcCtD
Etodolac—Erythema multiforme—Mesalazine—Crohn's disease	0.000181	0.00306	CcSEcCtD
Etodolac—Tinnitus—Mesalazine—Crohn's disease	0.000179	0.00302	CcSEcCtD
Etodolac—Sepsis—Prednisone—Crohn's disease	0.000175	0.00296	CcSEcCtD
Etodolac—Chills—Mesalazine—Crohn's disease	0.000172	0.00291	CcSEcCtD
Etodolac—Diarrhoea—Mercaptopurine—Crohn's disease	0.000172	0.0029	CcSEcCtD
Etodolac—Ill-defined disorder—Azathioprine—Crohn's disease	0.00017	0.00287	CcSEcCtD
Etodolac—Alopecia—Mesalazine—Crohn's disease	0.000169	0.00286	CcSEcCtD
Etodolac—Anaemia—Azathioprine—Crohn's disease	0.000169	0.00286	CcSEcCtD
Etodolac—Malaise—Azathioprine—Crohn's disease	0.000165	0.00279	CcSEcCtD
Etodolac—Flatulence—Mesalazine—Crohn's disease	0.000165	0.00278	CcSEcCtD
Etodolac—Leukopenia—Azathioprine—Crohn's disease	0.000164	0.00277	CcSEcCtD
Etodolac—Vascular purpura—Prednisone—Crohn's disease	0.000164	0.00277	CcSEcCtD
Etodolac—Tension—Mesalazine—Crohn's disease	0.000164	0.00277	CcSEcCtD
Etodolac—Dysgeusia—Mesalazine—Crohn's disease	0.000163	0.00276	CcSEcCtD
Etodolac—Nervousness—Mesalazine—Crohn's disease	0.000162	0.00274	CcSEcCtD
Etodolac—Cardiac failure congestive—Prednisone—Crohn's disease	0.000162	0.00273	CcSEcCtD
Etodolac—Vomiting—Mercaptopurine—Crohn's disease	0.00016	0.0027	CcSEcCtD
Etodolac—Rash—Mercaptopurine—Crohn's disease	0.000158	0.00267	CcSEcCtD
Etodolac—Dermatitis—Mercaptopurine—Crohn's disease	0.000158	0.00267	CcSEcCtD
Etodolac—Vision blurred—Mesalazine—Crohn's disease	0.000157	0.00266	CcSEcCtD
Etodolac—Tremor—Mesalazine—Crohn's disease	0.000156	0.00264	CcSEcCtD
Etodolac—Arthralgia—Azathioprine—Crohn's disease	0.000156	0.00264	CcSEcCtD
Etodolac—Myalgia—Azathioprine—Crohn's disease	0.000156	0.00264	CcSEcCtD
Etodolac—Ill-defined disorder—Mesalazine—Crohn's disease	0.000155	0.00262	CcSEcCtD
Etodolac—Anaemia—Mesalazine—Crohn's disease	0.000154	0.00261	CcSEcCtD
Etodolac—Discomfort—Azathioprine—Crohn's disease	0.000154	0.0026	CcSEcCtD
Etodolac—Angioedema—Mesalazine—Crohn's disease	0.000153	0.00258	CcSEcCtD
Etodolac—Purpura—Prednisone—Crohn's disease	0.000152	0.00257	CcSEcCtD
Etodolac—Malaise—Mesalazine—Crohn's disease	0.000151	0.00254	CcSEcCtD
Etodolac—Vertigo—Mesalazine—Crohn's disease	0.00015	0.00253	CcSEcCtD
Etodolac—Syncope—Mesalazine—Crohn's disease	0.00015	0.00253	CcSEcCtD
Etodolac—Leukopenia—Mesalazine—Crohn's disease	0.000149	0.00252	CcSEcCtD
Etodolac—Nausea—Mercaptopurine—Crohn's disease	0.000149	0.00252	CcSEcCtD
Etodolac—Infection—Azathioprine—Crohn's disease	0.000149	0.00251	CcSEcCtD
Etodolac—Palpitations—Mesalazine—Crohn's disease	0.000148	0.00249	CcSEcCtD
Etodolac—Loss of consciousness—Mesalazine—Crohn's disease	0.000147	0.00248	CcSEcCtD
Etodolac—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000147	0.00248	CcSEcCtD
Etodolac—Thrombocytopenia—Azathioprine—Crohn's disease	0.000146	0.00247	CcSEcCtD
Etodolac—PTGS2—gall bladder—Crohn's disease	0.000146	0.0557	CbGeAlD
Etodolac—Hypertension—Mesalazine—Crohn's disease	0.000144	0.00244	CcSEcCtD
Etodolac—Arthralgia—Mesalazine—Crohn's disease	0.000142	0.0024	CcSEcCtD
Etodolac—Myalgia—Mesalazine—Crohn's disease	0.000142	0.0024	CcSEcCtD
Etodolac—Anxiety—Mesalazine—Crohn's disease	0.000142	0.00239	CcSEcCtD
Etodolac—Discomfort—Mesalazine—Crohn's disease	0.00014	0.00237	CcSEcCtD
Etodolac—Irritability—Prednisone—Crohn's disease	0.00014	0.00237	CcSEcCtD
Etodolac—Hypotension—Azathioprine—Crohn's disease	0.00014	0.00236	CcSEcCtD
Etodolac—Dry mouth—Mesalazine—Crohn's disease	0.000139	0.00235	CcSEcCtD
Etodolac—Confusional state—Mesalazine—Crohn's disease	0.000137	0.00232	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000136	0.0023	CcSEcCtD
Etodolac—Anaphylactic shock—Mesalazine—Crohn's disease	0.000136	0.0023	CcSEcCtD
Etodolac—Oedema—Mesalazine—Crohn's disease	0.000136	0.0023	CcSEcCtD
Etodolac—Infection—Mesalazine—Crohn's disease	0.000135	0.00229	CcSEcCtD
Etodolac—Shock—Mesalazine—Crohn's disease	0.000134	0.00226	CcSEcCtD
Etodolac—Thrombocytopenia—Mesalazine—Crohn's disease	0.000133	0.00225	CcSEcCtD
Etodolac—Tachycardia—Mesalazine—Crohn's disease	0.000133	0.00225	CcSEcCtD
Etodolac—Hyperhidrosis—Mesalazine—Crohn's disease	0.000132	0.00223	CcSEcCtD
Etodolac—PTGS2—mouth—Crohn's disease	0.00013	0.0495	CbGeAlD
Etodolac—Anorexia—Mesalazine—Crohn's disease	0.00013	0.00219	CcSEcCtD
Etodolac—Abdominal distension—Prednisone—Crohn's disease	0.000128	0.00216	CcSEcCtD
Etodolac—Hypotension—Mesalazine—Crohn's disease	0.000127	0.00215	CcSEcCtD
Etodolac—Pancreatitis—Prednisone—Crohn's disease	0.000124	0.0021	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000124	0.0021	CcSEcCtD
Etodolac—Feeling abnormal—Azathioprine—Crohn's disease	0.000123	0.00208	CcSEcCtD
Etodolac—Insomnia—Mesalazine—Crohn's disease	0.000123	0.00208	CcSEcCtD
Etodolac—Paraesthesia—Mesalazine—Crohn's disease	0.000122	0.00207	CcSEcCtD
Etodolac—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000122	0.00207	CcSEcCtD
Etodolac—Dyspnoea—Mesalazine—Crohn's disease	0.000121	0.00205	CcSEcCtD
Etodolac—Somnolence—Mesalazine—Crohn's disease	0.000121	0.00205	CcSEcCtD
Etodolac—Dyspepsia—Mesalazine—Crohn's disease	0.00012	0.00203	CcSEcCtD
Etodolac—Neutropenia—Prednisone—Crohn's disease	0.000119	0.002	CcSEcCtD
Etodolac—Decreased appetite—Mesalazine—Crohn's disease	0.000118	0.002	CcSEcCtD
Etodolac—Abdominal pain—Azathioprine—Crohn's disease	0.000118	0.002	CcSEcCtD
Etodolac—Body temperature increased—Azathioprine—Crohn's disease	0.000118	0.002	CcSEcCtD
Etodolac—Fatigue—Mesalazine—Crohn's disease	0.000117	0.00198	CcSEcCtD
Etodolac—Pain—Mesalazine—Crohn's disease	0.000117	0.00197	CcSEcCtD
Etodolac—Constipation—Mesalazine—Crohn's disease	0.000117	0.00197	CcSEcCtD
Etodolac—Hyperglycaemia—Prednisone—Crohn's disease	0.000114	0.00193	CcSEcCtD
Etodolac—Feeling abnormal—Mesalazine—Crohn's disease	0.000112	0.0019	CcSEcCtD
Etodolac—Acute coronary syndrome—Prednisone—Crohn's disease	0.000111	0.00188	CcSEcCtD
Etodolac—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000111	0.00188	CcSEcCtD
Etodolac—Myocardial infarction—Prednisone—Crohn's disease	0.000111	0.00187	CcSEcCtD
Etodolac—Hypersensitivity—Azathioprine—Crohn's disease	0.00011	0.00186	CcSEcCtD
Etodolac—Urticaria—Mesalazine—Crohn's disease	0.000108	0.00183	CcSEcCtD
Etodolac—Body temperature increased—Mesalazine—Crohn's disease	0.000108	0.00182	CcSEcCtD
Etodolac—Abdominal pain—Mesalazine—Crohn's disease	0.000108	0.00182	CcSEcCtD
Etodolac—Diarrhoea—Azathioprine—Crohn's disease	0.000102	0.00173	CcSEcCtD
Etodolac—Haemoglobin—Prednisone—Crohn's disease	0.000102	0.00172	CcSEcCtD
Etodolac—Haemorrhage—Prednisone—Crohn's disease	0.000101	0.00171	CcSEcCtD
Etodolac—Hallucination—Prednisone—Crohn's disease	0.000101	0.00171	CcSEcCtD
Etodolac—Hypersensitivity—Mesalazine—Crohn's disease	0.0001	0.0017	CcSEcCtD
Etodolac—Dizziness—Azathioprine—Crohn's disease	9.89e-05	0.00167	CcSEcCtD
Etodolac—Asthenia—Mesalazine—Crohn's disease	9.78e-05	0.00165	CcSEcCtD
Etodolac—Pruritus—Mesalazine—Crohn's disease	9.64e-05	0.00163	CcSEcCtD
Etodolac—Vomiting—Azathioprine—Crohn's disease	9.51e-05	0.00161	CcSEcCtD
Etodolac—Rash—Azathioprine—Crohn's disease	9.43e-05	0.00159	CcSEcCtD
Etodolac—Dermatitis—Azathioprine—Crohn's disease	9.42e-05	0.00159	CcSEcCtD
Etodolac—Flushing—Prednisone—Crohn's disease	9.42e-05	0.00159	CcSEcCtD
Etodolac—Headache—Azathioprine—Crohn's disease	9.37e-05	0.00158	CcSEcCtD
Etodolac—Diarrhoea—Mesalazine—Crohn's disease	9.32e-05	0.00158	CcSEcCtD
Etodolac—Arrhythmia—Prednisone—Crohn's disease	9.06e-05	0.00153	CcSEcCtD
Etodolac—Dizziness—Mesalazine—Crohn's disease	9.01e-05	0.00152	CcSEcCtD
Etodolac—Alopecia—Prednisone—Crohn's disease	8.97e-05	0.00151	CcSEcCtD
Etodolac—PTGS1—Overview of nanoparticle effects—CXCL8—Crohn's disease	8.96e-05	0.00684	CbGpPWpGaD
Etodolac—RXRA—Bile acid and bile salt metabolism—ALB—Crohn's disease	8.92e-05	0.00681	CbGpPWpGaD
Etodolac—Nausea—Azathioprine—Crohn's disease	8.89e-05	0.0015	CcSEcCtD
Etodolac—UGT2B7—Metapathway biotransformation—GPX4—Crohn's disease	8.78e-05	0.0067	CbGpPWpGaD
Etodolac—Vomiting—Mesalazine—Crohn's disease	8.66e-05	0.00146	CcSEcCtD
Etodolac—Rash—Mesalazine—Crohn's disease	8.59e-05	0.00145	CcSEcCtD
Etodolac—Dermatitis—Mesalazine—Crohn's disease	8.58e-05	0.00145	CcSEcCtD
Etodolac—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	8.55e-05	0.00653	CbGpPWpGaD
Etodolac—Headache—Mesalazine—Crohn's disease	8.54e-05	0.00144	CcSEcCtD
Etodolac—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	8.43e-05	0.00644	CbGpPWpGaD
Etodolac—CYP2C9—Arachidonic acid metabolism—GPX4—Crohn's disease	8.33e-05	0.00636	CbGpPWpGaD
Etodolac—Vision blurred—Prednisone—Crohn's disease	8.32e-05	0.00141	CcSEcCtD
Etodolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Crohn's disease	8.27e-05	0.00631	CbGpPWpGaD
Etodolac—Ill-defined disorder—Prednisone—Crohn's disease	8.2e-05	0.00138	CcSEcCtD
Etodolac—Anaemia—Prednisone—Crohn's disease	8.16e-05	0.00138	CcSEcCtD
Etodolac—ALB—Folate Metabolism—GPX4—Crohn's disease	8.15e-05	0.00622	CbGpPWpGaD
Etodolac—Nausea—Mesalazine—Crohn's disease	8.09e-05	0.00137	CcSEcCtD
Etodolac—Angioedema—Prednisone—Crohn's disease	8.07e-05	0.00136	CcSEcCtD
Etodolac—PTGS2—Selenium Micronutrient Network—GPX4—Crohn's disease	8e-05	0.00611	CbGpPWpGaD
Etodolac—Malaise—Prednisone—Crohn's disease	7.97e-05	0.00135	CcSEcCtD
Etodolac—Vertigo—Prednisone—Crohn's disease	7.94e-05	0.00134	CcSEcCtD
Etodolac—Syncope—Prednisone—Crohn's disease	7.92e-05	0.00134	CcSEcCtD
Etodolac—PTGS1—epithelium—Crohn's disease	7.91e-05	0.0302	CbGeAlD
Etodolac—RXRA—Transcription factor regulation in adipogenesis—TNF—Crohn's disease	7.81e-05	0.00596	CbGpPWpGaD
Etodolac—Loss of consciousness—Prednisone—Crohn's disease	7.76e-05	0.00131	CcSEcCtD
Etodolac—PTGS1—Selenium Micronutrient Network—MPO—Crohn's disease	7.68e-05	0.00587	CbGpPWpGaD
Etodolac—PTGS1—Eicosanoid Synthesis—PTGS2—Crohn's disease	7.66e-05	0.00585	CbGpPWpGaD
Etodolac—Convulsion—Prednisone—Crohn's disease	7.65e-05	0.00129	CcSEcCtD
Etodolac—ALB—Vitamin B12 Metabolism—MPO—Crohn's disease	7.64e-05	0.00583	CbGpPWpGaD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—Crohn's disease	7.63e-05	0.00583	CbGpPWpGaD
Etodolac—Hypertension—Prednisone—Crohn's disease	7.63e-05	0.00129	CcSEcCtD
Etodolac—PTGS1—smooth muscle tissue—Crohn's disease	7.62e-05	0.0291	CbGeAlD
Etodolac—PTGS2—epithelium—Crohn's disease	7.56e-05	0.0288	CbGeAlD
Etodolac—PTGS1—skin of body—Crohn's disease	7.53e-05	0.0287	CbGeAlD
Etodolac—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	7.52e-05	0.00574	CbGpPWpGaD
Etodolac—Myalgia—Prednisone—Crohn's disease	7.52e-05	0.00127	CcSEcCtD
Etodolac—Arthralgia—Prednisone—Crohn's disease	7.52e-05	0.00127	CcSEcCtD
Etodolac—Anxiety—Prednisone—Crohn's disease	7.49e-05	0.00127	CcSEcCtD
Etodolac—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	7.45e-05	0.00569	CbGpPWpGaD
Etodolac—Discomfort—Prednisone—Crohn's disease	7.43e-05	0.00126	CcSEcCtD
Etodolac—PTGS2—smooth muscle tissue—Crohn's disease	7.29e-05	0.0278	CbGeAlD
Etodolac—Anaphylactic shock—Prednisone—Crohn's disease	7.21e-05	0.00122	CcSEcCtD
Etodolac—Oedema—Prednisone—Crohn's disease	7.21e-05	0.00122	CcSEcCtD
Etodolac—PTGS2—skin of body—Crohn's disease	7.19e-05	0.0274	CbGeAlD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	7.18e-05	0.00548	CbGpPWpGaD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	7.18e-05	0.00548	CbGpPWpGaD
Etodolac—Infection—Prednisone—Crohn's disease	7.16e-05	0.00121	CcSEcCtD
Etodolac—UGT1A9—Metapathway biotransformation—GPX4—Crohn's disease	7.13e-05	0.00545	CbGpPWpGaD
Etodolac—PTGS2—Overview of nanoparticle effects—CXCL8—Crohn's disease	7.11e-05	0.00543	CbGpPWpGaD
Etodolac—Shock—Prednisone—Crohn's disease	7.09e-05	0.0012	CcSEcCtD
Etodolac—ALB—Platelet degranulation—F5—Crohn's disease	7.07e-05	0.0054	CbGpPWpGaD
Etodolac—Tachycardia—Prednisone—Crohn's disease	7.04e-05	0.00119	CcSEcCtD
Etodolac—Hyperhidrosis—Prednisone—Crohn's disease	6.97e-05	0.00118	CcSEcCtD
Etodolac—Anorexia—Prednisone—Crohn's disease	6.87e-05	0.00116	CcSEcCtD
Etodolac—PTGS1—mammalian vulva—Crohn's disease	6.86e-05	0.0262	CbGeAlD
Etodolac—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	6.83e-05	0.00522	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—F5—Crohn's disease	6.74e-05	0.00514	CbGpPWpGaD
Etodolac—CYP2C9—digestive system—Crohn's disease	6.59e-05	0.0251	CbGeAlD
Etodolac—Musculoskeletal discomfort—Prednisone—Crohn's disease	6.57e-05	0.00111	CcSEcCtD
Etodolac—Insomnia—Prednisone—Crohn's disease	6.52e-05	0.0011	CcSEcCtD
Etodolac—Paraesthesia—Prednisone—Crohn's disease	6.47e-05	0.00109	CcSEcCtD
Etodolac—ALB—Selenium Micronutrient Network—GPX4—Crohn's disease	6.47e-05	0.00494	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	6.45e-05	0.00492	CbGpPWpGaD
Etodolac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	6.41e-05	0.00489	CbGpPWpGaD
Etodolac—Dyspepsia—Prednisone—Crohn's disease	6.35e-05	0.00107	CcSEcCtD
Etodolac—PTGS2—C-MYB transcription factor network—MPO—Crohn's disease	6.33e-05	0.00483	CbGpPWpGaD
Etodolac—RXRA—Transcription factor regulation in adipogenesis—IL6—Crohn's disease	6.3e-05	0.00481	CbGpPWpGaD
Etodolac—Decreased appetite—Prednisone—Crohn's disease	6.27e-05	0.00106	CcSEcCtD
Etodolac—PTGS1—Overview of nanoparticle effects—TNF—Crohn's disease	6.24e-05	0.00476	CbGpPWpGaD
Etodolac—Fatigue—Prednisone—Crohn's disease	6.22e-05	0.00105	CcSEcCtD
Etodolac—ALB—Folate Metabolism—MPO—Crohn's disease	6.21e-05	0.00474	CbGpPWpGaD
Etodolac—Constipation—Prednisone—Crohn's disease	6.16e-05	0.00104	CcSEcCtD
Etodolac—PTGS2—Selenium Micronutrient Network—MPO—Crohn's disease	6.1e-05	0.00466	CbGpPWpGaD
Etodolac—ALB—lymph node—Crohn's disease	6.03e-05	0.023	CbGeAlD
Etodolac—PTGS1—digestive system—Crohn's disease	6.02e-05	0.0229	CbGeAlD
Etodolac—Feeling abnormal—Prednisone—Crohn's disease	5.94e-05	0.001	CcSEcCtD
Etodolac—Gastrointestinal pain—Prednisone—Crohn's disease	5.9e-05	0.000996	CcSEcCtD
Etodolac—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	5.83e-05	0.00445	CbGpPWpGaD
Etodolac—PTGS2—lymphoid tissue—Crohn's disease	5.83e-05	0.0222	CbGeAlD
Etodolac—PTGS2—digestive system—Crohn's disease	5.75e-05	0.0219	CbGeAlD
Etodolac—Urticaria—Prednisone—Crohn's disease	5.73e-05	0.000968	CcSEcCtD
Etodolac—Abdominal pain—Prednisone—Crohn's disease	5.7e-05	0.000963	CcSEcCtD
Etodolac—Body temperature increased—Prednisone—Crohn's disease	5.7e-05	0.000963	CcSEcCtD
Etodolac—RXRA—Adipogenesis—SOCS1—Crohn's disease	5.52e-05	0.00422	CbGpPWpGaD
Etodolac—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	5.46e-05	0.00417	CbGpPWpGaD
Etodolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Crohn's disease	5.45e-05	0.00416	CbGpPWpGaD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Crohn's disease	5.35e-05	0.00408	CbGpPWpGaD
Etodolac—Hypersensitivity—Prednisone—Crohn's disease	5.31e-05	0.000897	CcSEcCtD
Etodolac—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	5.2e-05	0.00397	CbGpPWpGaD
Etodolac—Asthenia—Prednisone—Crohn's disease	5.17e-05	0.000874	CcSEcCtD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	5.14e-05	0.00392	CbGpPWpGaD
Etodolac—Pruritus—Prednisone—Crohn's disease	5.1e-05	0.000862	CcSEcCtD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	5.06e-05	0.00386	CbGpPWpGaD
Etodolac—PTGS1—Overview of nanoparticle effects—IL6—Crohn's disease	5.03e-05	0.00384	CbGpPWpGaD
Etodolac—PTGS2—Overview of nanoparticle effects—TNF—Crohn's disease	4.95e-05	0.00378	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—MPO—Crohn's disease	4.94e-05	0.00377	CbGpPWpGaD
Etodolac—Diarrhoea—Prednisone—Crohn's disease	4.93e-05	0.000833	CcSEcCtD
Etodolac—PTGS2—C-MYB transcription factor network—TAB1—Crohn's disease	4.77e-05	0.00364	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—SMAD3—Crohn's disease	4.77e-05	0.00364	CbGpPWpGaD
Etodolac—Dizziness—Prednisone—Crohn's disease	4.77e-05	0.000805	CcSEcCtD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	4.63e-05	0.00354	CbGpPWpGaD
Etodolac—Vomiting—Prednisone—Crohn's disease	4.58e-05	0.000774	CcSEcCtD
Etodolac—Rash—Prednisone—Crohn's disease	4.55e-05	0.000768	CcSEcCtD
Etodolac—Dermatitis—Prednisone—Crohn's disease	4.54e-05	0.000767	CcSEcCtD
Etodolac—Headache—Prednisone—Crohn's disease	4.52e-05	0.000763	CcSEcCtD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	4.48e-05	0.00342	CbGpPWpGaD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	4.47e-05	0.00341	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	4.37e-05	0.00334	CbGpPWpGaD
Etodolac—Nausea—Prednisone—Crohn's disease	4.28e-05	0.000724	CcSEcCtD
Etodolac—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	4.26e-05	0.00325	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.16e-05	0.00317	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.16e-05	0.00317	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	4.04e-05	0.00309	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—CRP—Crohn's disease	4.02e-05	0.00307	CbGpPWpGaD
Etodolac—PTGS2—Overview of nanoparticle effects—IL6—Crohn's disease	4e-05	0.00305	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—PTRF—Crohn's disease	3.88e-05	0.00297	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.81e-05	0.00291	CbGpPWpGaD
Etodolac—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	3.77e-05	0.00288	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	3.73e-05	0.00285	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	3.73e-05	0.00285	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	3.72e-05	0.00284	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—ICAM1—Crohn's disease	3.69e-05	0.00282	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.65e-05	0.00279	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.65e-05	0.00278	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.65e-05	0.00278	CbGpPWpGaD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	3.53e-05	0.00269	CbGpPWpGaD
Etodolac—PTGS1—lymph node—Crohn's disease	3.44e-05	0.0131	CbGeAlD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.4e-05	0.0026	CbGpPWpGaD
Etodolac—PTGS2—lymph node—Crohn's disease	3.29e-05	0.0125	CbGeAlD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	3.28e-05	0.0025	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—CRP—Crohn's disease	3.27e-05	0.00249	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—CRP—Crohn's disease	3.21e-05	0.00245	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.19e-05	0.00243	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—F5—Crohn's disease	3.14e-05	0.00239	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.1e-05	0.00237	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	3.1e-05	0.00236	CbGpPWpGaD
Etodolac—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	3.06e-05	0.00233	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—ICAM1—Crohn's disease	3e-05	0.00229	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.97e-05	0.00226	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—ICAM1—Crohn's disease	2.95e-05	0.00225	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.93e-05	0.00223	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.9e-05	0.00221	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PLA2G4F—Crohn's disease	2.89e-05	0.0022	CbGpPWpGaD
Etodolac—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—Crohn's disease	2.87e-05	0.00219	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	2.83e-05	0.00216	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—IFNG—Crohn's disease	2.81e-05	0.00214	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.78e-05	0.00212	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	2.71e-05	0.00207	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—GCKR—Crohn's disease	2.63e-05	0.00201	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	2.61e-05	0.00199	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—CRP—Crohn's disease	2.6e-05	0.00198	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.59e-05	0.00198	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.57e-05	0.00196	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	2.52e-05	0.00192	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—IL1B—Crohn's disease	2.51e-05	0.00191	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.46e-05	0.00188	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—ALB—Crohn's disease	2.46e-05	0.00188	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—MTMR3—Crohn's disease	2.45e-05	0.00187	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PLA2G4F—Crohn's disease	2.45e-05	0.00187	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	2.44e-05	0.00186	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—UBE2D1—Crohn's disease	2.43e-05	0.00186	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TLR4—Crohn's disease	2.43e-05	0.00186	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.42e-05	0.00185	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—ICAM1—Crohn's disease	2.39e-05	0.00182	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.34e-05	0.00179	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—ICAM1—Crohn's disease	2.33e-05	0.00178	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—ZFP36L1—Crohn's disease	2.33e-05	0.00178	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	2.32e-05	0.00177	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PLA2G4F—Crohn's disease	2.29e-05	0.00175	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IFNG—Crohn's disease	2.29e-05	0.00174	CbGpPWpGaD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	2.28e-05	0.00174	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.27e-05	0.00173	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.26e-05	0.00173	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—CD4—Crohn's disease	2.25e-05	0.00172	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—IFNG—Crohn's disease	2.24e-05	0.00171	CbGpPWpGaD
Etodolac—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.24e-05	0.00171	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—STAT3—Crohn's disease	2.18e-05	0.00166	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—MTMR3—Crohn's disease	2.09e-05	0.00159	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	2.05e-05	0.00157	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IL1B—Crohn's disease	2.04e-05	0.00156	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—IL1B—Crohn's disease	2e-05	0.00153	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PLA2G4F—Crohn's disease	1.99e-05	0.00152	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.99e-05	0.00152	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—DNMT3A—Crohn's disease	1.98e-05	0.00151	CbGpPWpGaD
Etodolac—RXRA—Metabolism—MTMR3—Crohn's disease	1.95e-05	0.00149	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.92e-05	0.00147	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.92e-05	0.00146	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—FADS1—Crohn's disease	1.91e-05	0.00146	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.9e-05	0.00145	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.9e-05	0.00145	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—TNF—Crohn's disease	1.89e-05	0.00144	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—IL3—Crohn's disease	1.88e-05	0.00144	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	1.83e-05	0.0014	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	1.82e-05	0.00139	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—TNF—Crohn's disease	1.82e-05	0.00139	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—IFNG—Crohn's disease	1.82e-05	0.00139	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.8e-05	0.00137	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GPX4—Crohn's disease	1.79e-05	0.00137	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	1.77e-05	0.00135	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—SMAD3—Crohn's disease	1.74e-05	0.00133	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	1.74e-05	0.00133	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GCKR—Crohn's disease	1.73e-05	0.00132	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—MTMR3—Crohn's disease	1.7e-05	0.00129	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	1.65e-05	0.00126	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—SMAD3—Crohn's disease	1.64e-05	0.00125	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.63e-05	0.00125	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PLA2G4F—Crohn's disease	1.63e-05	0.00124	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—FADS1—Crohn's disease	1.63e-05	0.00124	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	1.62e-05	0.00124	CbGpPWpGaD
Etodolac—ALB—Hemostasis—F5—Crohn's disease	1.62e-05	0.00123	CbGpPWpGaD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.61e-05	0.00123	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	1.58e-05	0.00121	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.55e-05	0.00119	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GPX4—Crohn's disease	1.52e-05	0.00116	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—IL6—Crohn's disease	1.52e-05	0.00116	CbGpPWpGaD
Etodolac—RXRA—Metabolism—FADS1—Crohn's disease	1.52e-05	0.00116	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—TNF—Crohn's disease	1.48e-05	0.00113	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	1.48e-05	0.00113	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GCKR—Crohn's disease	1.47e-05	0.00112	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	1.47e-05	0.00112	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.45e-05	0.00111	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	1.45e-05	0.00111	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GPX4—Crohn's disease	1.42e-05	0.00108	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.39e-05	0.00106	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—MTMR3—Crohn's disease	1.38e-05	0.00106	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GCKR—Crohn's disease	1.37e-05	0.00105	CbGpPWpGaD
Etodolac—PTGS2—Disease—RSPO3—Crohn's disease	1.35e-05	0.00103	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—HSPA1B—Crohn's disease	1.34e-05	0.00102	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.34e-05	0.00102	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—FADS1—Crohn's disease	1.32e-05	0.00101	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	1.32e-05	0.00101	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PLA2G4F—Crohn's disease	1.29e-05	0.000985	CbGpPWpGaD
Etodolac—PTGS2—Disease—SEL1L—Crohn's disease	1.28e-05	0.000975	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.27e-05	0.00097	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GPX4—Crohn's disease	1.24e-05	0.000944	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GCKR—Crohn's disease	1.19e-05	0.000912	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IL6—Crohn's disease	1.19e-05	0.000911	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.19e-05	0.000909	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.18e-05	0.000901	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	1.18e-05	0.000897	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	1.17e-05	0.000895	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—UBE2D1—Crohn's disease	1.17e-05	0.000895	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	1.15e-05	0.000877	CbGpPWpGaD
Etodolac—PTGS2—Disease—LTF—Crohn's disease	1.15e-05	0.000874	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—MTMR3—Crohn's disease	1.1e-05	0.000838	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—FADS1—Crohn's disease	1.08e-05	0.000822	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TYK2—Crohn's disease	1.07e-05	0.000816	CbGpPWpGaD
Etodolac—ALB—Metabolism—PLA2G4F—Crohn's disease	1.04e-05	0.000797	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—JAK2—Crohn's disease	1.02e-05	0.000779	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GPX4—Crohn's disease	1.01e-05	0.00077	CbGpPWpGaD
Etodolac—ALB—Hemostasis—ITGA4—Crohn's disease	9.94e-06	0.000759	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	9.8e-06	0.000748	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GCKR—Crohn's disease	9.74e-06	0.000743	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IL3—Crohn's disease	9.69e-06	0.00074	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	9.48e-06	0.000724	CbGpPWpGaD
Etodolac—ALB—Hemostasis—RASGRP1—Crohn's disease	9.38e-06	0.000716	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—ALB—Crohn's disease	9.32e-06	0.000711	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	9.27e-06	0.000708	CbGpPWpGaD
Etodolac—PTGS2—Disease—GCKR—Crohn's disease	9.23e-06	0.000705	CbGpPWpGaD
Etodolac—ALB—Metabolism—MTMR3—Crohn's disease	8.88e-06	0.000678	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	8.85e-06	0.000676	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	8.57e-06	0.000654	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—FADS1—Crohn's disease	8.55e-06	0.000653	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	8.55e-06	0.000652	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	8.54e-06	0.000652	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—SMAD3—Crohn's disease	8.38e-06	0.00064	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	8.18e-06	0.000624	CbGpPWpGaD
Etodolac—PTGS2—Disease—SLC11A1—Crohn's disease	8.16e-06	0.000623	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GPX4—Crohn's disease	8e-06	0.000611	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	7.81e-06	0.000596	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GCKR—Crohn's disease	7.73e-06	0.00059	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—STAT3—Crohn's disease	7.49e-06	0.000572	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.47e-06	0.00057	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—MTMR3—Crohn's disease	7.27e-06	0.000555	CbGpPWpGaD
Etodolac—PTGS2—Disease—RBX1—Crohn's disease	7e-06	0.000534	CbGpPWpGaD
Etodolac—PTGS2—Disease—HSPA1B—Crohn's disease	7e-06	0.000534	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.96e-06	0.000531	CbGpPWpGaD
Etodolac—ALB—Metabolism—FADS1—Crohn's disease	6.92e-06	0.000528	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IL2RA—Crohn's disease	6.79e-06	0.000518	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TNF—Crohn's disease	6.48e-06	0.000495	CbGpPWpGaD
Etodolac—ALB—Metabolism—GPX4—Crohn's disease	6.48e-06	0.000494	CbGpPWpGaD
Etodolac—ALB—Metabolism—GCKR—Crohn's disease	6.25e-06	0.000477	CbGpPWpGaD
Etodolac—PTGS2—Disease—UBE2D1—Crohn's disease	6.13e-06	0.000468	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.09e-06	0.000465	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—FADS1—Crohn's disease	5.66e-06	0.000432	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.52e-06	0.000422	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—ALB—Crohn's disease	5.5e-06	0.00042	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GPX4—Crohn's disease	5.3e-06	0.000405	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—IL6—Crohn's disease	5.23e-06	0.000399	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GCKR—Crohn's disease	5.12e-06	0.000391	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTGS2—Crohn's disease	4.81e-06	0.000367	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—ALB—Crohn's disease	4.68e-06	0.000357	CbGpPWpGaD
Etodolac—ALB—Hemostasis—JAK2—Crohn's disease	4.56e-06	0.000348	CbGpPWpGaD
Etodolac—PTGS2—Disease—SMAD3—Crohn's disease	4.39e-06	0.000335	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ALB—Crohn's disease	4.36e-06	0.000333	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTGS2—Crohn's disease	4.09e-06	0.000312	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.91e-06	0.000299	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTGS2—Crohn's disease	3.82e-06	0.000291	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ALB—Crohn's disease	3.8e-06	0.00029	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.66e-06	0.000279	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTGS2—Crohn's disease	3.33e-06	0.000254	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.2e-06	0.000244	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ALB—Crohn's disease	3.1e-06	0.000237	CbGpPWpGaD
Etodolac—PTGS2—Disease—TYK2—Crohn's disease	2.86e-06	0.000219	CbGpPWpGaD
Etodolac—PTGS2—Disease—JAK2—Crohn's disease	2.73e-06	0.000208	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTGS2—Crohn's disease	2.71e-06	0.000207	CbGpPWpGaD
Etodolac—PTGS2—Disease—CD4—Crohn's disease	2.59e-06	0.000198	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ALB—Crohn's disease	2.46e-06	0.000188	CbGpPWpGaD
Etodolac—PTGS2—Disease—STAT3—Crohn's disease	2e-06	0.000153	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTGS2—Crohn's disease	1.74e-06	0.000133	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALB—Crohn's disease	1.63e-06	0.000124	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTGS2—Crohn's disease	1.43e-06	0.000109	CbGpPWpGaD
Etodolac—PTGS2—Disease—IL6—Crohn's disease	1.4e-06	0.000107	CbGpPWpGaD
